Inhibition of dibutyryl cyclic AMP-induced insulin release by alpha-2 adrenergic stimulation

Life Sci. 1983 Jan 17;32(3):191-5. doi: 10.1016/0024-3205(83)90030-9.

Abstract

Effects of alpha adrenergic agonists and antagonists on dibutyryl cAMP (Bt2cAMP)-induced insulin release were investigated with isolated rat pancreatic islets. Bt2cAMP (4 mM) produced 2-fold stimulation of insulin release in all the concentrations of glucose examined (3.3-16.7 mM). Clonidine but not phenylephrine inhibited the Bt2cAMP-stimulated insulin release in a concentration-dependent manner with approximate EC50 of nanomolar range. Yohimbine but not prazosin antagonized the inhibitory effect of clonidine on the Bt2-cAMP-induced insulin release. These results suggest that alpha-2 adrenergic mechanisms are involved in a step distal to cAMP generation.

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology*
  • Adrenergic alpha-Antagonists / pharmacology*
  • Animals
  • Bucladesine / antagonists & inhibitors
  • Bucladesine / pharmacology
  • Insulin / metabolism*
  • Insulin Secretion
  • Islets of Langerhans / metabolism*
  • Male
  • Rats
  • Receptors, Adrenergic, alpha / drug effects
  • Secretory Rate / drug effects

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic alpha-Antagonists
  • Insulin
  • Receptors, Adrenergic, alpha
  • Bucladesine